Class II
Ongoing
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well pharma of Houston, NDC 73702-203-65.
Why: cGMP deviations.
- Company
- Wells Pharma of Houston LLC
Houston, TX, United States - Reported
- May 6, 2026
- Recall started
- Apr 1, 2026
- Where sold
- U.S. Nationwide.
- Amount
- 150 syringes
- Full product description
- fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well pharma of Houston, NDC 73702-203-65.
- Lots / codes affected
- Lot 022326203650432; Exp Date 06/25/2026
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.